Experience with ebrantil used in patients with resistant arterial hypertension in chronic kidney disease
Summary. Aim. To evaluate the clinical efficacy of ebrantil used in patients with resistant arterial hypertension (RAH) in Stage III-V chronic kidney disease (CKD). Subjects and methods. Sixty-five patients with Stage III-V CKD and RAH (systolic blood pressure (SBP) 215.7±4.0 mm Hg and diastolic blo...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
"Consilium Medicum" Publishing house
2012-08-01
|
| Series: | Терапевтический архив |
| Subjects: | |
| Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31108 |